Market Overview:
The global neurovascular catheters market size reached US$ 3.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 5.8 Billion by 2032, exhibiting a growth rate (CAGR) of 6.8% during 2024-2032. The increasing prevalence of neurovascular diseases, rapid technological advancements in catheter design, materials, and imaging techniques, the rising aging population, and the growing awareness about neurovascular disorders and their early diagnosis are some of the factors propelling the market.
Report Attribute
|
Key Statistics
|
Base Year
|
2023 |
Forecast Years
|
2024-2032
|
Historical Years
|
2018-2023
|
Market Size in 2023 |
US$ 3.2 Billion |
Market Forecast in 2032 |
US$ 5.8 Billion |
Market Growth Rate (2024-2032) |
6.8% |
Neurovascular catheters are specialized medical devices designed to diagnose and treat conditions affecting the blood vessels in the brain. These catheters are used in neuro-interventional procedures to access the intricate network of vessels within the central nervous system. By inserting these catheters through a small incision, physicians can deliver medications, inject contrast dye for imaging, or perform minimally invasive procedures like angioplasty or embolization. They are made of biocompatible materials, ensuring compatibility with delicate vascular structures. They feature flexible shafts with a variety of shapes and sizes to navigate complex anatomical pathways. These catheters are crucial in diagnosing and treating strokes, aneurysms, arteriovenous malformations (AVMs), and intracranial hemorrhages. Their minimally invasive nature reduces the risks associated with open surgery, leading to shorter hospital stays, faster recovery, and improved patient outcomes.
The global market is majorly driven by the rising incidence of conditions such as strokes, aneurysms, and arteriovenous malformations (AVMs). In line with this, the rising demand for minimally invasive procedures is significantly contributing to the market. Furthermore, the growing aging population, which is more prone to neurovascular diseases, is positively influencing the market. Apart from this, the escalating awareness about neurovascular disorders and the importance of early diagnosis are creating a positive outlook for the market. Moreover, improved access to healthcare facilities and the expansion of hospitals and specialized centers are driving the adoption of neurovascular catheters. Besides, the increasing healthcare expenditure in developed and developing countries supports the market. Additionally, numerous favorable reimbursement policies for neurovascular interventions and associated devices, including catheters, are stimulating the market.
Neurovascular Catheters Market Trends/Drivers:
Increasing research and development activities
The increasing research and development (R&D) efforts focused on the development of advanced neurovascular catheters are offering numerous opportunities for the market. These R&D activities aim to improve the performance, safety, and effectiveness of neurovascular catheters, addressing the evolving needs of patients and healthcare providers. By investing in R&D, medical device manufacturers can introduce innovative catheter designs, incorporate advanced materials, and leverage cutting-edge technologies. This leads to the development of catheters that offer improved navigation capabilities, enhanced flexibility, better visualization, and reduced procedural risks. Advanced neurovascular catheters developed through ongoing R&D efforts enable physicians to perform complex procedures with greater precision, accuracy, and efficacy. They allow for better access to challenging anatomical regions and enable the delivery of therapeutic agents directly to the targeted site. Furthermore, R&D activities also contribute to the introduction of novel features such as integrated micro-guidewires, enhanced trackability, and compatibility with advanced imaging techniques. These advancements enhance clinical outcomes and patient experience, increasing adoption and market expansion.
Rapid introduction of new neurovascular catheter products
The introduction of new neurovascular catheter products with enhanced features and improved performance is catalyzing the market. Medical device manufacturers continually strive to develop and launch catheters that offer better navigation, increased flexibility, improved trackability, and enhanced imaging capabilities. These new catheter products address the evolving needs of healthcare providers and patients by providing advanced solutions for diagnosing and treating neurovascular conditions. They offer greater precision and control during procedures, allowing physicians to access intricate vascular networks in the brain with higher success rates. The integration of innovative materials and technologies in these new catheters results in improved durability, maneuverability, and biocompatibility. Enhanced features such as radiopaque markers, microcatheter compatibility, and variable stiffness options enable better visualization, precise placement, and efficient delivery of therapeutic agents. Furthermore, the introduction of new neurovascular catheters also fosters competition in the market, encouraging further advancements and innovation. Healthcare providers and patients benefit from a wider range of options, leading to increased adoption and market expansion.
Rising demand for image-guided procedures
The rising demand for image-guided neurovascular procedures is propelling the market. Image-guided procedures, such as angiography and endovascular interventions, rely heavily on using catheters to navigate the complex vasculature of the brain. These procedures provide real-time visualization of blood vessels, allowing physicians to diagnose and treat neurovascular conditions accurately. Neurovascular catheters play a crucial role in accessing and maneuvering within these delicate vessels under imaging guidance, ensuring precise placement and targeted delivery of therapies. Several factors drive the demand for image-guided procedures. These procedures offer less invasive alternatives to traditional open surgeries, resulting in reduced patient trauma, shorter hospital stays, and faster recovery times. They also allow for more accurate diagnosis and treatment planning, improving patient outcomes. As the awareness of the benefits of image-guided procedures grows among healthcare providers and patients, the demand for neurovascular catheters rises correspondingly. Consequently, medical device manufacturers are investing in developing catheters specifically designed to facilitate image-guided interventions, further bolstering the market.
Neurovascular Catheters Industry Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global neurovascular catheters market report, along with forecasts at the global, regional and country levels for 2024-2032. Our report has categorized the market based on type, application, and end user.
Breakup by Type:
- Microcatheters
- Balloon Catheters
- Access Catheters
- Embolization Catheters
- Others
Embolization Catheters dominates the market
The report has provided a detailed breakup and analysis of the market based on type. This includes microcatheters, balloon catheters, access catheters, embolization catheters, and others. According to the report, embolization catheters represented the largest segment.
Embolization catheters are used in embolization procedures to block or reduce blood flow to abnormal vessels, such as aneurysms or AVMs. These catheters facilitate the precise placement of embolic materials, leading to targeted occlusion and improved patient outcomes. The increasing prevalence of neurovascular conditions requiring embolization procedures fuels the market growth for embolization catheters.
On the contrary, microcatheters, with their small diameter and high flexibility, are specifically designed for intricate neurovascular procedures. They allow precise navigation through narrow and tortuous vessels, enabling targeted delivery of therapeutic agents and improving treatment outcomes.
Furthermore, balloon catheters are used in angioplasty procedures to treat stenosis or occlusions in blood vessels. These catheters, equipped with inflatable balloons, help restore blood flow by dilating narrowed vessels, contributing to the market growth through the increasing demand for endovascular interventions.
Moreover, access catheters are crucial in accessing the target site within the neurovascular system. These catheters provide a pathway for other devices, such as microcatheters or guidewires, to reach the desired location for diagnosis or treatment. The growing adoption of access catheters in neurovascular procedures drives the market expansion.
Breakup by Application:
- Embolic Stroke
- Brain Aneurysms
- Arteriovenous Malformations
- Others
Brain Aneurysms holds the largest share of the market
A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes embolic stroke, brain aneurysms, arteriovenous malformations, and others. According to the report, brain aneurysms accounted for the largest market share.
Brain aneurysms are abnormal bulges in blood vessels within the brain that pose a risk of rupture. Neurovascular catheters, such as balloon and access catheters, are used in endovascular coiling or embolization procedures to treat aneurysms. The rising incidence of brain aneurysms and the shift towards less invasive treatment options contribute to the market growth in this segment.
On the contrary, embolic stroke, caused by a blood clot that blocks an artery in the brain, is a critical condition that requires prompt intervention. Neurovascular catheters, particularly those designed for clot retrieval and thrombectomy, are crucial in removing the clot and restoring blood flow to the brain. The increasing prevalence of embolic strokes and the growing adoption of minimally invasive catheter procedures are catalyzing the market expansion.
Moreover, arteriovenous malformations (AVMs) are abnormal tangles of blood vessels that disrupt normal blood flow and increase the risk of bleeding in the brain. Neurovascular catheters, particularly those used in embolization procedures, are instrumental in blocking or reducing blood flow to AVMs, minimizing the risk of rupture. The increasing recognition and diagnosis of AVMs catalyze the demand for neurovascular catheters for AVM treatment.
Breakup by End User:
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Diagnostic Centers
Hospitals holds the largest share of the market
A detailed breakup and analysis of the market based on the end user have also been provided in the report. This includes hospitals, clinics, ambulatory surgical centers, and diagnostic centers. According to the report, hospitals accounted for the largest market share.
Hospitals are the primary end users of neurovascular catheters due to their comprehensive healthcare infrastructure and the ability to handle complex neurovascular cases. The increasing demand for neurovascular procedures and the availability of specialized healthcare professionals in hospitals drive the the market in this segment.
Furthermore, the clinics play a significant role in diagnosing and treating neurovascular conditions. With advancements in technology and the availability of specialized neurovascular equipment, clinics are increasingly adopting neurovascular catheters to provide minimally invasive procedures to patients. The convenience, accessibility, and shorter waiting times offered by clinics contribute to the market expansion.
Moreover, ambulatory surgical centers (ASCs) are gaining prominence in the neurovascular catheters market. These centers provide outpatient neurovascular procedures, offering convenience, cost-effectiveness, and reduced hospital stays. The trend of shifting surgeries from hospitals to ASCs, coupled with advancements in catheter technology, is driving growth in this segment.
Besides, the diagnostic centers utilize neurovascular catheters for diagnostic imaging procedures, such as angiography and cerebral blood flow measurements. These centers play a crucial role in detecting and accurately diagnosing neurovascular conditions. The increasing demand for diagnostic procedures and the availability of advanced imaging technologies support the market growth in this segment.
Breakup by Region:
- North America
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Others
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Latin America
- Middle East and Africa
North America exhibits a clear dominance, accounting for the largest market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa.
North America is a major market for neurovascular catheters. The region has a well-established infrastructure, high healthcare expenditure, and advanced medical technologies. The increasing prevalence of neurovascular diseases and a rising aging population drive the demand for neurovascular catheters in North America. Additionally, favorable reimbursement policies and strong investments in research and development contribute to the market growth in this region.
On the other hand, Europe is another prominent market for neurovascular catheters. The region boasts a sophisticated healthcare system and a high focus on technological advancements in medical devices. The increasing awareness about neurovascular conditions, favorable government initiatives, and the presence of leading neurovascular catheter manufacturers stimulate the market in Europe.
Competitive Landscape:
Top neurovascular catheter companies are vital in strengthening the market expansion. These companies invest heavily in research and development to innovate and introduce advanced catheter technologies that enhance performance, safety, and efficacy. They focus on improving navigation capabilities, flexibility, and compatibility with imaging techniques. Furthermore, these companies leverage strategic collaborations and partnerships with healthcare institutions to expand their reach and ensure wider adoption of their products. They also actively engage in marketing and promotional activities to raise awareness among healthcare providers about the benefits of their neurovascular catheters. Moreover, top companies invest in training and education programs for healthcare professionals to enhance their skills and knowledge regarding neurovascular interventions. This facilitates the proper and effective utilization of neurovascular catheters.
The report has provided a comprehensive analysis of the competitive landscape in the neurovascular catheters market. Detailed profiles of all major companies have also been provided.
- Acandis GmbH
- Biomerics LLC
- Imperative Care Inc.
- Integer Holdings Corporation
- Johnson and Johnson
- Medtronic plc
- Penumbra, Inc.
- Phenox GmbH (Wallaby Medical)
- Raumedic AG (Rehau Group)
- Spiegelberg GmbH & Co. KG
- Stryker Corporation
- Terumo Corporation
Neurovascular Catheters Market Report Scope:
Report Features |
Details |
Base Year of the Analysis |
2023 |
Historical Period |
2018-2023 |
Forecast Period |
2024-2032 |
Units |
US$ Billion |
Scope of the Report |
Exploration of Historical and Forecast Trends, Industry Catalysts and Challenges, Segment-Wise Historical and Predictive Market Assessment:
- Type
- Application
- End User
- Region
|
Types Covered |
Microcatheters, Balloon Catheters, Access Catheters, Embolization Catheters, Others |
Applications Covered |
Embolic Stroke, Brain Aneurysms, Arteriovenous Malformations, Others |
End Users Covered |
Hospitals, Clinics, Ambulatory Surgical Centers, Diagnostic Centers |
Regions Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered |
Acandis GmbH, Biomerics LLC, Imperative Care Inc., Integer Holdings Corporation, Johnson and Johnson, Medtronic plc, Penumbra, Inc., Phenox GmbH (Wallaby Medical), Raumedic AG (Rehau Group), Spiegelberg GmbH & Co. KG, Stryker Corporation, Terumo Corporation, etc. |
Customization Scope |
10% Free Customization |
Report Price and Purchase Option |
Single User License: US$ 3899
Five User License: US$ 4899
Corporate License: US$ 5899 |
Post-Sale Analyst Support |
10-12 Weeks |
Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
- How has the global neurovascular catheters market performed so far, and how will it perform in the coming years?
- What are the drivers, restraints, and opportunities in the global neurovascular catheters market?
- What is the impact of each driver, restraint, and opportunity on the global neurovascular catheters market?
- What are the key regional markets?
- Which countries represent the most attractive neurovascular catheters market?
- What is the breakup of the market based on the type?
- Which is the most attractive type in the global neurovascular catheters market?
- What is the breakup of the market based on the application?
- Which is the most attractive application in the global neurovascular catheters market?
- What is the breakup of the market based on the end user?
- Which is the most attractive end user in the global neurovascular catheters market?
- What is the competitive structure of the global neurovascular catheters market?
- Who are the key players/companies in the global neurovascular catheters market?
Key Benefits for Stakeholders:
- IMARC’s report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the neurovascular catheters market from 2018-2032.
- The research study provides the latest information on the market drivers, challenges, and opportunities in the neurovascular catheters market.
- The study maps the leading, as well as the fastest-growing, regional markets. It further enables stakeholders to identify the key country-level markets within each region.
- Porter's five forces analysis assists stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the global neurovascular catheters industry and its attractiveness.
- Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.